Ewan Forrest

Managing patients with advanced liver disease in alcohol withdrawal is challenging. See our published experience with symptom-triggered GMAWS favouring lorazepam use. Effective and safe. #livertwitter @BASLedu @EASLedu @FrontGastro_BMJ

…ea01.safelinks.protection.outlook.com/?url=http%3A%2…

Great to see a description of the work of the Scottish Hepatology Access Research Partnership published: an important step to improve liver care for patients. @ruairilynch @dr_rach_swann @dnblane @sharphepatology @BASLedu @NIHRresearch
openresearch.nihr.ac.uk/articles/4-58/…

Pleased to see the publication of our paper showing effective management of alcohol withdrawal syndrome in patients with coexistent alcohol-related liver disease using GMAWS.
#LiverTwitter @BASLedu @BritSocGastro @FrontGastro_BMJ
fg.bmj.com/content/early/…

Great to see the work of the Scottish Hepatology Access Research Partnership published by NIHR Open Research. Important collaboration to improve access to liver services. @ruairilynch @LiverTrust @JAFallowfield @dnblane @NIHRresearch @dr_rach_swann
openresearch.nihr.ac.uk/articles/4-58/…

Not everyone drinking excess alcohol will develop liver disease. Great work @fredho42, @Fanny_Petermann et al showing additive interaction of diet and alcohol for ArLD, after controlling for MASLD risks. @SALVE_liver @ebtapper #livertwitter

nature.com/articles/s4146…